Decreased radioiodine uptake of FRTL-5 cells after 131I incubation in vitro: Molecular biological investigations indicate a cell cycle-dependent pathway

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 6, 2008, Pages 1204-1212

  Meller, Birgit ^a   Gaspar, Erzsébet ^a   Deisting, Wibke ^a   Czarnocka, Barbara ^b   Baehre, Manfred ^a   Wenzel, Björn E ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

FRTL5; NIS; Radioiodine treatment; Stunning; Thyroid

Indexed keywords

BETA ACTIN; IODINE 131; MESSENGER RNA; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL LEVEL; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; DRUG HALF LIFE; HOUSEKEEPING GENE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

ANIMALS; CELL CYCLE; CELL LINE; IODINE RADIOISOTOPES; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; THYROID GLAND;

EID: 43749122067     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0666-0     Document Type: Article

References (37)

1. 131I. J Nucl Med. 2000;41:198-02.
2. 123I. Eur J Nucl Med. 2002;29:783-8.
3. 131I diagnostic activities on the biokinetics of thyroid remnants. J Nucl Med. 2004;45:619-25.
4. 131I. Eur J Nucl Med Mol Imaging. 2002;29:421-7.
5. Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hanscheid H, et al. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2003;30:1371-7.
6. Medvedec M. Seeking a radiobiological explanation for thyroid stunning. Eur J Nucl Med. 2001;28:393-5.
7. 131I-scanned and nonscanned individuals. J Clin Endocrinol Metab. 2001;86:3507-11.
8. Park HM, Perkins OW, Edmondson JW, Schnute RB, Manatunga A. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid. 1994;4:49-54.
9. Urhan M, Dadparvar S, Mavi A, Houseni M, Chamroonrat W, Alavi A, et al. Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging. 2007;34:1012-7.
10. Wu HS, Hseu HH, Lin WY, Wang SJ, Liu YC. Decreased uptake after fractionated ablative doses of iodine-131. Eur J Nucl Med Mol Imaging. 2005;32:67-73.
11. Verburg FA, de Keizer B, Lips CJM, Zelissen PMJ, de Klerk JMH. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol. 2005;152:33-7.
12. Dietlein M, Dressler J, Farahati J, Grunwald F, Leisner B, Moser E, et al. Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2). Nuklearmedizin. 2004;43:115-20.
13. Cooper DS, Doherty GM, Haugen BR, Kloss RT, Lee S, Mandel S, et al. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-42.
14. Gerard SK, Park HM. Stunning and I-123 Use for Diagnostic Whole Body Scanning. Thyroid. 2006;16:817.
15. Postgard P, Himmelmann J, Lindencrona U, Bhogal N, Wiberg D, Berg G, et al. Stunning of iodide transport by 131I irradiation in cultured thyroid epithelial cells. J Nucl Med. 2002;43:818-34.
16. Ambesi-Impiombato FS, Parks LAM, Coon HG. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci U S A. 1980;77:3455-9.
17. Weiss SJ, Philip NJ, Grollman EF. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology. 1984;114:1090-8.
18. Grollman EF, Smolar A, Tombaccini D, Santisteban P. Iodine suppression of iodide uptake in FRTL-5 thyroid cells. Endocrinology. 1986;118:2477-82.
19. Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE. Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol. 2001;144:139-44.
20. Leer LM, Ossendorp FA, de Vijlder JJM. TSH action on iodination in FRTL-5 cells. Horm Metab Res Suppl. 1990;23:43-6.
21. Weiss SJ, Philip NJ, Ambesi-Impiombato FS, Grollman EF. Thyrotropin-stimulated iodide transport mediated by cyclic AMP and dependent on protein synthesis. Endocrinology. 1984;114:1099-107.
22. Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco N. Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity. J Biol Chem. 1997;272:27230-8.
23. Meller B, Deisting W, Wenzel BE, Pethe A, Nadrowitz R, Meller J, et al. Increased Radioiodine Uptake of Thyroid Cell Cultures after External Irradiation. Strahlenther Onkol. 2006;182:30-6.
24. Bauer R. Physikalische Grundlagen der Radioiodtherapie. In: Radiojodtherapie bei Schilddrüsenerkrankungen. Indikationen - Ergebnisse - Nebenwirkungen. pp 3-21. Ed G Buttermann. Frankfurt: pmi;1987.
25. Wawschinek O, Eber O, Petek W, Wakönig P, Gürakar A. Bestimmung der Harniodausscheidung mittels einer modifizierten Cer-Arsenitmethode. Berichte der ÖGKC. 1985;8:13-5.
26. Studer H, Ramelli F. Simple goiter and its variants: euthyroid and hyperthyroid multinodular goiters. Endocr Rev. 1982;3:40-61.
27. 131I-induced release of "cold" iodine stored in the thyroid. Nuklearmedizin. 2005;44:137-42.
28. 131I diagnostic activities and radioiodine therapy on urinary iodine excretion in patients with differentiated thyroid carcinoma. Nuklearmedizin. 2005;44:243-7.
29. 131I therapy and radioiodine kinetics. Nuklearmedizin. 1996;35:175-80.
30. Nuchel C, Boddenberg B, Schicha H. The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases. Nuklearmedizin. 1993;32:91-8.
31. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid. 1999;9:821-30.
32. Appelskog IB, Ammerpohl O, Svechnikova IG, Lui WO, Almqvist PM, Ekstrom TJ. Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells. Int J Oncol. 2004;24:1419-25.
33. Fareh J, Martel R, Kermani P Leclerc G. Cellular effects of beta-particle delivery on vascular smooth muscle cells and endothelial cells: a dose-response study. Circulation. 1999;99:1477-84.
34. Klett R, Puille M, Steiner D, Bauer R. Einfluss des Applikationsabstandes auf den thyreoidalen Uptake bei zweizeitiger Radiojodtherapie. Nuklearmedizin. 2000;39:A91.
35. Schumm-Draeger PM. Sodium/iodide symporter (NIS) and cytokines. Exp Clin Endocrinol Diabetes. 2001;109:32-4.
36. Arturi F, Presta I, Scarpelli D, Bidart J-M, Schlumberger M, Filetti S, et al. Stimulation of iodide uptake by human chorionic gonadotropin in FRTL-5 cells: effects on sodium/iodide symporter gene and protein expression. Eur J Endocrinol. 2002;147:655-61.
37. Arai M, Tsushima T, Isozaki O Demura H, Shizume K, Emoto N, et al. Effects of transforming growth factor alpha (TGF-alpha) on DNA synthesis and thyrotropin-induced iodine metabolism in cultured porcine thyroid cells. Eur J Endocrinol. 1995;132:242-8.